Aida Azizii's Remarkable Journey: Overcoming PCOS and Transforming from Size 22 to 10

Aida Azizii's journey from a size 22 dress to a size 10 is nothing short of extraordinary. For nearly a decade, the London-based personal assistant battled polycystic ovary syndrome (PCOS), a hormonal disorder affecting one in ten women in Britain. Diagnosed at 16, she endured a relentless cycle of weight gain, irregular periods, and unwanted facial hair—symptoms that left her feeling isolated and ashamed. Doctors prescribed metformin, a common treatment for PCOS, which initially helped her shed pounds. But the drug came with severe side effects: nausea so intense it forced her to stop. "After that, my weight spiralled," she recalls. "I was always starving, eating more just to feel full." At 25, she weighed 21 stone and wore black to mask her figure, avoiding photos on social media out of fear of judgment.

Her turning point came when she discovered inositol, a little-known supplement priced at just 30p per capsule. Online testimonials from other women with PCOS caught her attention. "I'd tried everything—drugs, diets, nothing worked," she says. After consulting her GP, who gave the green light, Aida began taking one capsule daily. Within weeks, the cravings for sugary foods vanished. "It was like a switch flipped," she explains. As the pounds melted away, she found the courage to start exercising. Over time, she increased her dose to four capsules a day—aligned with clinical studies—leading to a staggering nine-stone weight loss in a year. Today, she wears a size 10 and speaks passionately about how inositol transformed her life.

The science behind inositol's success is gaining traction. A recent review published in the *Journal of Clinical Endocrinology* analyzed data from over 400 women with PCOS and found compelling evidence that the supplement can rebalance hormones, addressing symptoms like facial hair growth, acne, and fertility challenges. Known as Vitamin B8, inositol naturally occurs in foods like rice and fruits but is often consumed in concentrated doses through supplements. Researchers believe it mimics the effects of metformin, a drug used to manage insulin levels in type 2 diabetes patients. Dr. Channa Jayasena, a reproductive endocrinologist at Imperial College London, notes that inositol and metformin both influence insulin regulation, a key factor in PCOS. "The medical community is increasingly recognizing inositol's weight-loss benefits," he says.

Clinical trials further validate these claims. A 2017 study found that women with PCOS who took inositol experienced weight loss comparable to those on metformin. Another analysis of nine trials concluded that long-term use (over 24 weeks) improved metabolic markers, including reduced blood sugar and weight loss. These findings have not gone unnoticed by the NHS, which now recommends inositol for PCOS patients in some hospitals. Yet experts caution that while the evidence is promising, more research is needed to fully understand its long-term effects.

For Aida, however, the results speak for themselves. "I never thought I'd be here," she says, looking at her before-and-after photos. "Inositol gave me my life back." As more women seek alternatives to traditional treatments, the supplement's potential to alleviate PCOS symptoms—without the harsh side effects of drugs—is becoming a beacon of hope. But with growing interest comes a need for caution: always consult a healthcare professional before starting any new supplement regimen. The story of inositol is still unfolding, but for now, it's offering a lifeline to thousands grappling with a condition that has long felt unmanageable.

Dr. Jayasena, a physician with a growing interest in integrative health approaches, recently began recommending myo-inositol to two patients as part of a broader strategy to manage metabolic health. The supplement, a naturally occurring compound found in foods like nuts, seeds, and whole grains, has gained attention in recent years for its potential role in regulating insulin sensitivity and supporting hormonal balance. While Dr. Jayasena highlights anecdotal improvements in energy levels and metabolic markers among his patients, he acknowledges the supplement's use remains controversial within the medical community.

The scientific debate surrounding inositol is far from settled. Professor Naveed Sattar, a leading metabolic researcher at the University of Glasgow, has raised concerns about the limited scope of existing studies. "Research on inositol as a weight-loss tool only really took off about a decade ago," he explains. "There's still not enough high-quality, long-term data to make definitive claims about its efficacy or safety." His skepticism is rooted in the challenges of isolating inositol's effects from other variables, such as lifestyle changes.

Sattar points to a common criticism of supplements: the difficulty in distinguishing between placebo effects and actual physiological benefits. "People who take inositol and report weight loss might simply be adhering to stricter diets or exercising more," he says. "They attribute the results to the pill, but it's hard to prove causality without rigorous clinical trials." This argument underscores a broader issue in nutritional science—the reliance on self-reported outcomes and the lack of standardized dosing protocols for supplements like inositol.

Despite these uncertainties, some patients and practitioners remain convinced of inositol's potential. Advocates cite preliminary studies suggesting it may improve insulin signaling in individuals with prediabetes or metabolic syndrome. However, Sattar emphasizes that such findings are often based on small sample sizes or animal models, which may not translate to human outcomes. He also warns against overreliance on unproven interventions, particularly in the absence of regulatory oversight for many dietary supplements.

The conversation around inositol reflects a larger tension in modern medicine: the push for evidence-based treatments versus the demand for alternatives that offer hope in the face of chronic conditions. While Dr. Jayasena continues to monitor his patients' progress, Sattar urges caution. "We need more robust research before we can say inositol is a game-changer," he says. "For now, it's best to view it as a complementary tool, not a standalone solution."

This debate is unlikely to resolve anytime soon. As interest in inositol grows, so too does the pressure on researchers to conduct larger, more rigorous studies. Until then, patients and doctors alike are left navigating a landscape of promise and uncertainty, where the line between hype and hard science remains blurred.